People
Kelly Girskis
Kelly Girskis was publicly named by Arkuda Therapeutics as Board Member. Her archived2024 issuer biography identifies an abrdn investment-director role following the October2023 Tekla transition, and previous Tekla research work covering private and public biotech. Her background includes SVB Leerink and Ascentia Asset Management and neuroscience training. Arkuda affiliation is historical; continued employment or board membership after the2025 asset sale is unverified.
Roles
abrdn Inc.
CurrentAffiliated Investment Director (Aberdeen Group)
Arkuda Therapeutics
CurrentBoard Member (archived company roster; historical, current status unverified)
Tekla Capital Management
2023-10-27Vice President, Research — historical